- LDS
- /Medical Tests
- /Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis
Diseases (1)Access to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
OverviewAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
Clinical UtilityAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
InterpretationAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
Reference RangesAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
MethodologyAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
Turnaround TimeAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
CPTAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
LOINCAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
ICD10Access to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
Additional ICD10Access to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.
ReferencesAccess to Serine Peptidase Inhibitor, Kazal type 1 (SPINK1) Gene Mutation Analysis for Pancreatitis is restricted.